Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

5-Aminoisoquinolin-1-one and other water-soluble PARP inhibitors

M. Threadgill, J. Berry, S. Ferrer, I. Parveen, A. Shinkwin, E. Woon

Med Sci Monit 2003; 9(1): 71-0 :: ID: 15214


Inhibitors of the activity of PARP have applications in the treatment of many disease states. Most of the known inhibitors of PARP mimic the nicotinamide of the substrate NAD+. The consensus pharmacophore for PARP inhibitors is a primary or secondary benzamide with N–H conformationally constrained anti to the carbonyl-arene bond. However, this can also be considered as a ‘pharmacophore’ for insolubility in water. In this presentation, the results of our work on extending this pharmacophore into heterocyclyl carboxamides, into more water-soluble inhibitors and into potential prodrugs will be outlined. For example, 5-substituted isoquinolin-1-ones and 2, 8-substituted quinazolin-4-ones are known [1,2] to be potent inhibitors of PARP; we have shown [3] that the analogous thieno [3,4-c]pyridin-4(5H)-ones and thieno [3,4-d]pyrimidin-4(3H)-ones are also strongly active. New synthetic routes to 5-aminoisoquinolin-1-one (5-AIQ) have been developed [4], making this inhibitor more readily available. 5-AIQ shows IC50 = 250 nM against PARP activity in a broken nuclear preparation; its corresponding IC50 against a mono-ADP-ribosyl transferase (diphtheria toxin) is 80 KM, making 5-AIQ highly selective for PARP. This compound is highly water-soluble as its hydrochloride, making it suitable for rapid i.v. administration. 5-AIQ protects against organ damage in a rat model of haemorrhagic shock at the remarkably low dose of 30 KgŠKg–1. It is similarly active in vivo in models of myocardial infarction and acute lung inflammation. Potential bioreductively activated prodrugs of this and other isoquinolin-1-ones have been synthesised [5,6] and are shown to release drug rapidly in experimental systems; these include 2-(2-nitroimidazol-5-ylmethyl)isoquinolin-1-ones and 1, 2-dimethyl-3-(isoquinolin-1-yloxymethyl)-5-methoxyindole-4, 7-diones. Further developments from these leads are under active research. References: 1.Suto MJ, Turner WR et al: Anti-Cancer Drug Design, 1991; 7: 107 2.Griffin RJ, Pemberton LC et al: Anti-Cancer Drug Design, 1995; 10: 507 3.Shinkwin AE, Whish WJD, Threadgill MD: Bioorg Med Chem, 1999; 7: 297 4.McDonald MC, Mota-Filipe H, Wright JA et al: Br J Pharmacol, 2000; 130: 843 5.Parveen I, Naughton DP et al: Bioorg Med Chem Lett, 1999; 9: 2031 6.Ferrer S, Naughton DP, Parveen I et al: J Chem Soc Perkin Trans, 2002; 1: 335

Keywords: 5-Aminoisoquinolin-1-one, thieno [3,4-c]pyridin-4(5H)-one, prodrug, Solubility, Reperfusion

Add Comment 0 Comments


01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204


In Press

15 Jan 2024 : Clinical Research  

Comparison of Modified Shock Index and Shock Index for Predicting Massive Transfusion in Women with Primary...

Med Sci Monit In Press; DOI: 10.12659/MSM.943286  


15 Jan 2024 : Database Analysis  

Bibliometric Analysis of Brain Stimulation Technologies in Sleep Disorders

Med Sci Monit In Press; DOI: 10.12659/MSM.942687  

15 Jan 2024 : Clinical Research  

Clinical Outcomes of Arthroscopic Surgery in Patients with Gluteal Muscle Contracture: Single-Institution R...

Med Sci Monit In Press; DOI: 10.12659/MSM.942945  

17 Jan 2024 : Laboratory Research  

Impact of Auxiliary Features on Retention of Short Dental Crowns: An In-Vitro Analysis of Box and Groove Pr...

Med Sci Monit In Press; DOI: 10.12659/MSM.943401  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750